載入...
The association between BMI and BSA–temozolomide-induced myelosuppression toxicities: a correlative analysis of NRG oncology RTOG 0525
BACKGROUND: Fearing increased myelotoxicity, many practitioners adjust the body surface area (BSA)-calculated doses in obese patients. Regarding temozolomide (TMZ), a prior study suggested men with a BSA >2 m(2) may experience increased toxicity; however, surprisingly, the inverse observation was...
Na minha lista:
| 發表在: | Neurooncol Pract |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Oxford University Press
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6899045/ https://ncbi.nlm.nih.gov/pubmed/31832217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nop/npz006 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|